Keurig Dr Pepper (NYSE:KDP) PT Raised to $26.00

Share on StockTwits

Keurig Dr Pepper (NYSE:KDP) had its price objective upped by research analysts at Morgan Stanley from $24.00 to $26.00 in a note issued to investors on Friday, Stock Target Advisor reports. The brokerage presently has an “underweight” rating on the stock. Morgan Stanley’s price target suggests a potential downside of 10.96% from the company’s current price.

Several other research firms also recently commented on KDP. Guggenheim reaffirmed a “hold” rating on shares of Keurig Dr Pepper in a report on Friday, September 27th. SunTrust Banks set a $35.00 price objective on shares of Keurig Dr Pepper and gave the stock a “buy” rating in a report on Friday, September 27th. ValuEngine raised shares of Keurig Dr Pepper from a “sell” rating to a “hold” rating in a report on Friday, November 1st. Credit Suisse Group initiated coverage on shares of Keurig Dr Pepper in a report on Wednesday, July 17th. They issued a “neutral” rating and a $27.00 price objective for the company. Finally, Bank of America raised their price objective on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the stock a “buy” rating in a report on Friday, August 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. Keurig Dr Pepper has an average rating of “Buy” and an average price target of $30.57.

KDP traded down $0.63 on Friday, hitting $29.20. The company’s stock had a trading volume of 2,595,503 shares, compared to its average volume of 2,524,521. The company’s 50 day simple moving average is $27.60 and its 200-day simple moving average is $28.22. The firm has a market cap of $39.43 billion, a P/E ratio of 28.08, a price-to-earnings-growth ratio of 1.51 and a beta of 0.45. Keurig Dr Pepper has a 12 month low of $24.52 and a 12 month high of $32.00. The company has a quick ratio of 0.23, a current ratio of 0.33 and a debt-to-equity ratio of 0.58.

Keurig Dr Pepper (NYSE:KDP) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.01. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.86 billion. Keurig Dr Pepper had a net margin of 8.82% and a return on equity of 7.15%. Keurig Dr Pepper’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period last year, the firm earned $0.30 EPS. Equities analysts predict that Keurig Dr Pepper will post 1.22 earnings per share for the current fiscal year.

In other news, insider Mary Beth Denooyer purchased 6,000 shares of the business’s stock in a transaction on Tuesday, August 27th. The stock was purchased at an average cost of $26.78 per share, with a total value of $160,680.00. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert S. Singer purchased 3,000 shares of the business’s stock in a transaction on Tuesday, August 13th. The stock was purchased at an average cost of $28.65 per share, with a total value of $85,950.00. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 105,727 shares of company stock valued at $2,609,271. Insiders own 0.44% of the company’s stock.

Large investors have recently made changes to their positions in the business. Nuveen Asset Management LLC purchased a new stake in shares of Keurig Dr Pepper during the 2nd quarter valued at $346,987,000. D. E. Shaw & Co. Inc. raised its position in shares of Keurig Dr Pepper by 177.6% during the 2nd quarter. D. E. Shaw & Co. Inc. now owns 9,578,432 shares of the company’s stock valued at $276,816,000 after buying an additional 6,128,458 shares in the last quarter. Prudential Financial Inc. raised its position in shares of Keurig Dr Pepper by 426.3% during the 2nd quarter. Prudential Financial Inc. now owns 3,429,881 shares of the company’s stock valued at $99,124,000 after buying an additional 2,778,138 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Keurig Dr Pepper by 24.6% during the 2nd quarter. Vanguard Group Inc. now owns 13,724,226 shares of the company’s stock valued at $396,631,000 after buying an additional 2,713,806 shares in the last quarter. Finally, Invesco Ltd. raised its position in shares of Keurig Dr Pepper by 225.1% during the 2nd quarter. Invesco Ltd. now owns 1,565,946 shares of the company’s stock valued at $45,255,000 after buying an additional 1,084,276 shares in the last quarter. 19.54% of the stock is owned by hedge funds and other institutional investors.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.

Featured Story: Momentum Investing

Stock Target Advisor

Analyst Recommendations for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.